GCC 2546- Motion Management
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Maryland, Baltimore
About this trial
The purpose of this study is to assess a real time motion tracking of lung tumors and important organs next to the tumor while breathing during a participant's radiation treatment. This will be assessed through a four-dimensional magnetic resonance imaging (MRI) scan before starting your radiation treatment and x-ray fluoroscopy images that are taken during radiation
Eligibility criteria
Qualifiers
Adult (≥18 years) patients (both sexes) with histologically diagnosed Stage II-IIIb NSCLC
Patients to be treated with definitive external beam photon radiotherapy with or without systemic therapy (e.g., chemotherapy, immunotherapy).
No restrictions on number radiotherapy fractions, or location/number of lesions
ECOG performance status ≤ 3
Disqualifiers
Pre-existing contraindications for MRI, such as any MRI-conditional or MRI-unsafe foreign objects within the body, non-removable ear cochlear or eye implant, aneurysm clip, cardiac pacemaker/wires, internal defibrillator, tissue expander, recent stent placement, penile prosthesis, medication patch, artificial limb, pregnancy, and claustrophobia
Women who are pregnant or trying to get pregnant (self-reported)
Pain in supine position or inability to raise arm above head in supine position
Trial design
Treatments tested in this trial
- MRI
Treatment groups
44 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov